MedTrace Logo

Comparison of Misoprostol and Prostaglandin E2 (PGE2) Gel for Induction of Labour in Premature Rupture of Membranes at Term

NCT00355303 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 932

Last updated 2015-07-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether induction of labor with vaginal misoprostol application will result in fewer cesarean deliveries than vaginal PGE2 gel application in women with premature rupture of membranes at term.

Conditions

  • Premature Rupture of Membranes at Term

Interventions

DRUG

Misoprostol

Vaginal application of Misoprostol tablets at 4 hrly interval with maximumof five doses

DRUG

PGE2 gel

PGE2 gel will be applied in poaterior fornix at six hrly interval with maximum of 2 doses

Sponsors & Collaborators

  • Nilratan Sircar Medical College

    lead OTHER_GOV

Principal Investigators

  • Snehamay Chaudhuri, MBBS,MD.DNB · Nilratan Sircar Medical College , Kolkata, West bengal , India

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • India

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00355303 on ClinicalTrials.gov